AnalystsTerence Flynn
Terence Flynn's Stock Forecasts

Analyst Ranking
Top 7%
#343 out of 4868 analysts
Average Return
+12.11%
Win Rate
60%58 out of 96
Risk vs Reward
Poor
Good

Terence Flynn's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Translate Bio IncTBIO1
+147.91%$15.07$37.36
2020-10-04 -
2021-09-14
Strong Buy
Blueprint Medicines CorpBPMC
+140.20%$41.34$99.30
2017-03-12 -
2018-03-13
Strong Buy
Eli Lilly & CoLLY
+139.90%$314.17$753.68
2023-02-28 -
2024-02-29
Strong Buy
Eli Lilly & CoLLY
+106.33%$367.00$757.24
2023-04-09 -
2024-04-09
Strong Buy
Eli Lilly & CoLLY
+96.90%$339.08$667.65
2023-02-02 -
2024-02-02
Strong Buy

Terence Flynn Analyst Color

Get additional color on Terence Flynn's coverage of popular stocks

Terence Flynn's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Abbvie IncABBV
16Strong Buy$250.00+28.14%Maintains
3 days ago
Johnson & JohnsonJNJ
21Hold$169.00+8.12%Maintains
15 days ago
Organon & CoOGN
9Hold$15.00+16.01%Maintains
22 days ago
Eli Lilly & CoLLY
17Strong Buy$1,124.00+25.03%Maintains
22 days ago
Amgen IncAMGN
6Hold$330.00+13.43%Maintains
22 days ago
Arvinas IncARVN
7Hold$12.00+24.74%Maintains
2 months ago
Biontech SeBNTX
2Strong Buy$139.00+33.46%Maintains
2 months ago
Biohaven LtdBHVN
2Strong Buy$63.00+184.81%Maintains
2 months ago
Arcus Biosciences IncRCUS
5Strong Buy$25.00+185.71%Maintains
2 months ago
Crispr Therapeutics AgCRSP
7Strong Sell$32.00-17.25%Maintains
3 months ago
Merck & Co IncMRK
15Hold$106.00+24.41%Maintains
3 months ago
Nurix Therapeutics IncNRIX
4Hold$17.00+47.44%Maintains
3 months ago
Intellia Therapeutics IncNTLA
5Hold$11.00+24.01%Downgrades
3 months ago
Bristol Myers Squibb CoBMY
9Strong Sell$39.00-22.31%Maintains
6 months ago
Pfizer IncPFE
17Hold$31.00+27.00%Maintains
6 months ago
Structure Therapeutics IncGPCR
1Strong Buy$118.00+337.04%Initiates Coverage On
7 months ago
Alumis IncALMS
1Strong Buy$36.00+769.57%Initiates Coverage On
9 months ago
Royalty Pharma PLCRPRX
11Strong Buy$51.00+55.39%Maintains
10 months ago
United Therapeutics CorpUTHR
8Hold$321.00+5.91%Downgrades
10 months ago
Blueprint Medicines CorpBPMC
5Strong Buy$168.00+87.71%Maintains
a year ago
C4 Therapeutics IncCCCC
5Hold$8.00N/AMaintains
a year ago
Revance Therapeutics IncRVNC
7Hold$12.00N/AMaintains
2 years ago
Neuehealth IncNEUE
1Strong Buy$2,880.00N/AInitiates Coverage On
4 years ago
Biogen IncBIIB
2Hold$436.00N/AMaintains
4 years ago
Translate Bio IncTBIO1
1Strong Buy$342.00N/AInitiates Coverage On
5 years ago
Acceleron Pharma IncXLRN
2Hold$40.00N/AUpgrades
7 years ago
Alnylam Pharmaceuticals IncALNY
1Strong BuyN/AN/AUpgrades
8 years ago
Fibrogen IncFGEN
1HoldN/AN/ADowngrades
8 years ago
Bioverativ IncBIVV
1HoldN/AN/ADowngrades
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.